The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2024

Filed:

Mar. 10, 2020
Applicant:

Bayer Healthcare Llc, Whippany, NJ (US);

Inventors:

Karym El Sayed, Berlin, DE;

Henry Hernaez, Pittsburgh, PA (US);

Nivitha Mahesh, Murrysville, PA (US);

Wei Liao, Frankfurt am Main, DE;

Franco Fois, Monheim, DE;

Daniel Rechsteiner, Cologne, DE;

Jacob Agris, Great Neck Estates, NY (US);

Mohammad Sedigh Ghamari, Jersey City, NJ (US);

Xiangzhen Gao, Sterling Heights, MI (US);

Prahlad Menon Gopalakrishna, Bethel Park, PA (US);

Assignee:

BAYER HEALTHCARE LLC, Whippany, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/00 (2017.01); G06T 7/11 (2017.01); G06T 7/12 (2017.01); G06V 10/25 (2022.01); G06V 10/774 (2022.01); G16H 30/20 (2018.01);
U.S. Cl.
CPC ...
G06T 7/0012 (2013.01); G06T 7/11 (2017.01); G06T 7/12 (2017.01); G06V 10/25 (2022.01); G06V 10/774 (2022.01); G16H 30/20 (2018.01); G06T 2207/20081 (2013.01); G06T 2207/30048 (2013.01); G06T 2207/30061 (2013.01);
Abstract

Described are systems and methods for assessing a likelihood of chronic thromboembolic pulmonary hypertension (CTEPH) within a subject patient based upon an analysis of characteristics indicative of chronic thromboembolic pulmonary hypertension within an imaging study of the subject patient. The systems and methods can identify characteristics of one or more anatomical structures within a cardiac region of the subject patient indicative of CTEPH, characteristics of a pulmonary vasculature of the subject patient indicative of CTEPH, and characteristics of a chronic abnormality in a lung of the subject patient indicative of CTEPH. The systems and methods can assess these characteristics to compute the likelihood of CTEPH within the subject patient.


Find Patent Forward Citations

Loading…